Is Jisandai (Bingtonsha) included in medical insurance? How much does it cost?

Epclusa (Epclusa) is an oral antiviral drug developed by Gilead Sciences for the treatment of chronic hepatitis C virus (HCV) infection, specifically targeting all genotypes of HCV (1-6 types). The drug consists of Sofosbuvir (Sofosbuvir) and Velpatasvir (Velpatasvir). Sofosbuvir is an NS5B polymerase inhibitor that prevents viral RNA replication. Velpatasvir is an NS5A inhibitor that works by inhibiting viral replication and virus particle assembly. The two ingredients work synergistically to significantly improve the efficacy against different genotypes of HCV.

Jisandai (Bingtonsha) is now on the market in China and has been included in the medical insurance catalog. Patients can purchase it domestically, and its price is about more than 3,000 yuan. For specific prices and medical insurance reimbursement policies, please consult your local hospital or pharmacy for detailed information. In comparison, the price of generic drugs produced in India and Bangladesh is relatively low, only about a few hundred yuan, and the main ingredients of these drugs are basically the same as the domestic versions.

Jisandai (Bingtonsha) is suitable for the treatment of chronic hepatitis C of all genotypes, and is suitable for patients without cirrhosis and compensated cirrhosis. For patients with decompensated cirrhosis, it needs to be used in combination with ribavirin (Ribavirin). The standard treatment plan for Jisandai (Bingtonsha) is to take one tablet orally every day for 12 weeks. For some special cases, the treatment period may be extended. During medication, it is recommended to take it at the same time every day to maintain stable drug concentration.

In clinical trials, Jisandai (Bingtonsha) showed a high cure rate (SVR12, that is, the virus is undetectable 12 weeks after treatment), and the cure rate for various genotypes exceeded 95%. Common side effects include headache, fatigue, and nausea, which are usually mild or moderate. Patients should undergo regular liver function tests during medication and closely monitor the side effects and efficacy of the medication.